Johnson & Johnson Nanobiotix S.A. Transaction History
Johnson & Johnson
- $475 Million
- Q1 2024
A detailed history of Johnson & Johnson transactions in Nanobiotix S.A. stock. As of the latest transaction made, Johnson & Johnson holds 5,623,816 shares of NBTX stock, worth $28.1 Million. This represents 7.7% of its overall portfolio holdings.
Number of Shares
5,623,816
Previous 959,637
486.04%
Holding current value
$28.1 Million
Previous $8.4 Million
335.37%
% of portfolio
7.7%
Previous 3.25%
Shares
2 transactions
Others Institutions Holding NBTX
# of Institutions
13Shares Held
9.31MCall Options Held
0Put Options Held
0-
Baillie Gifford & CO2.87MShares$14.3 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY555KShares$2.78 Million0.08% of portfolio
-
Black Rock Inc. New York, NY253KShares$1.27 Million0.0% of portfolio
-
Ubs Group Ag3.1KShares$15,5000.0% of portfolio
-
Gamma Investing LLC Foster City, CA1.15KShares$5,7500.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $174M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...